Before 2004, it did not happen.
Before we put the national health products regulations in, we did not have a premarket system, so before products were on the market, they weren't being reviewed. We have that now.
Actually, that is one part of the system—whether it's been the OAG or others who have looked at it—that is said to be running well. The standards for approval for authorization before the products go on the market are done, and they're working well.